NOCIL Limited Reports 20% Q1 FY27 Revenue Growth, 9% Volume Gain

NOCIL Limited reported 20% year-on-year revenue growth and 9% volume growth in Q1 FY27, according to its August 2026 earnings-call transcript, while management retained FY27 revenue guidance of ₹1,400-1,600 crore and an EBITDA margin target of about 10%.

What did NOCIL Limited report for Q1 FY27?

NOCIL Limited reported year-on-year revenue growth of 20% and volume growth of 9% for the quarter ended June 30, 2026. The company discussed its operational and financial performance during its Q1 FY27 earnings conference call held on August 4, 2026.

The available earnings-call summary attributed the quarter's performance to strong demand from the tyre sector and improved margins. The supplied disclosure does not state the absolute quarterly revenue, EBITDA, profit, or share-price movement. Therefore, the reported percentage growth figures provide the clearest disclosed measure of the quarter's operating performance.

NOCIL is a chemicals company listed on the BSE under code 500730 and on the NSE under the symbol NOCIL. Its earnings-call transcript was submitted as an intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

When was the Q1 FY27 transcript disclosed to exchanges?

NOCIL disclosed the transcript of its August 4, 2026 earnings call on August 10, 2026. The filing stated that the call covered the company's operational and financial performance for the quarter ended June 30, 2026.

The transcript carries the date and time stamp of August 10, 2026 at 16:22:37 IST. NOCIL also noted that, in the event of a discrepancy, the audio recording uploaded on the stock exchange on August 4, 2026 would prevail over the transcript.

This distinction matters because transcripts are records of management discussions rather than a replacement for the underlying audio disclosure. For investors, the filing confirms that the company has formally placed the call record in the public domain under the exchange disclosure framework.

What financial targets has NOCIL retained for FY27?

NOCIL has guided for FY27 revenue of ₹1,400-1,600 crore, volume growth of 8%-10%, and an EBITDA margin of about 10%. The Q1 FY27 call summary also referred to new capacity and anti-dumping duties as factors supporting the company's future growth plans.

The ₹1,400-1,600 crore range is the principal absolute financial target disclosed in the supplied material. Management's guidance places the Q1 performance in the context of a full-year plan that depends on both higher volumes and margin execution.

How do anti-dumping proceedings relate to NOCIL's business?

NOCIL has continued to pursue anti-dumping petitions on selected products, an issue referenced across its recent earnings-call disclosures. In its Q4 FY26 call, the company said the Director General of Trade Remedies had recommended positive final findings in March 2026 for antioxidant TDQ and sulphenamides covering CBS and NS.

The Q1 FY27 material again referred to anti-dumping duties as a support factor alongside capacity additions. The provided text does not specify the final status, duty rates, implementation dates, or financial impact of any action discussed in the August 2026 call. Those details should not be inferred from the transcript notice alone.

Historically, NOCIL's FY26 discussions also highlighted pricing pressure, higher costs, export volatility and domestic-volume growth. The company had described anti-dumping action and cost efficiencies as areas of focus, while linking planned capacity and product launches to expected volume expansion.

What does the update mean for NOCIL investors and operations?

The Q1 FY27 update indicates that NOCIL began the financial year with revenue and volume growth, with tyre-sector demand identified as a contributor. The 9% volume increase sits within the company's FY27 volume-growth guidance of 8%-10%, although a single quarter does not establish full-year delivery.

For investors, the relevant disclosed benchmarks are the ₹1,400-1,600 crore revenue range and the approximately 10% EBITDA margin target. The supplied material does not provide quarterly profit, debt, cash flow, utilisation, export sales, or a market-price reaction, so the effect on valuation or earnings estimates cannot be determined from this announcement.

For customers and the rubber-chemicals industry, the call points to continued attention on capacity, product availability and trade-remedy proceedings. But NOCIL has not disclosed in the supplied text any change in customer pricing, supply arrangements, plant operations, or production volumes by product.

Conclusion

NOCIL's Q1 FY27 earnings-call transcript records 20% year-on-year revenue growth and 9% volume growth, supported by strong tyre-sector demand and improved margins. The update also confirms that management continues to frame new capacity and anti-dumping duties as relevant to its operating outlook.

The next disclosed benchmark is progress toward FY27 revenue of ₹1,400-1,600 crore, volume growth of 8%-10%, and an EBITDA margin of about 10%. Investors will also watch for further official updates on anti-dumping proceedings and any subsequent quarterly disclosures containing absolute financial figures.